Provided by Tiger Trade Technology Pte. Ltd.

Regenxbio

10.31
-0.0200-0.19%
Post-market: 8.50-1.8086-17.54%19:59 EST
Volume:955.42K
Turnover:9.86M
Market Cap:521.92M
PE:-2.98
High:10.62
Open:10.14
Low:10.01
Close:10.33
52wk High:16.19
52wk Low:5.04
Shares:50.62M
Float Shares:41.42M
Volume Ratio:1.13
T/O Rate:2.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4644
EPS(LYR):-4.5871
ROE:-76.88%
ROA:-18.54%
PB:3.23
PE(LYR):-2.25

Loading ...

Regenxbio price target lowered to $45 from $50 at Clear Street

TIPRANKS
·
6 hours ago

Stocks to Watch: Goodyear Tire, On Semiconductor, RegenexBio, Upwork

Dow Jones
·
7 hours ago

Regenxbio's Gene Therapy for Hunter Syndrome Fails to Win FDA Approval

MT Newswires Live
·
7 hours ago

BRIEF-REGENXBIO Announces Regulatory Update on RGX-121 BLA for MPS II

Reuters
·
8 hours ago

Regenxbio falls 21% to $8.10 after FDA issues CRL for BLA for RGX-121

TIPRANKS
·
8 hours ago

US FDA declines to approve Regenxbio's rare disease drug

Reuters
·
8 hours ago

Regenxbio says FDA issues CRL regarding BLA for RGX-121

TIPRANKS
·
9 hours ago

REGENXBIO trading halted, news pending

TIPRANKS
·
9 hours ago

Regenxbio Inc - FDA Issues Complete Response Letter for Rgx-121

THOMSON REUTERS
·
9 hours ago

Regenxbio Announces Regulatory Update on Rgx-121 Bla for Mps Ii

THOMSON REUTERS
·
9 hours ago

Regenxbio Inc - Plans to Resubmit Bla for Rgx-121

THOMSON REUTERS
·
9 hours ago

Regenxbio Inc - Requests Type a Meeting With FDA to Discuss Rgx-121 Crl

THOMSON REUTERS
·
9 hours ago

NASDAQ TRADE HALT HALT NEWS PENDING AT 04:01 PM

Reuters
·
9 hours ago

REGENXBIO Is Maintained at Buy by Chardan Capital

Dow Jones
·
Jan 29

Nippon Shinyaku Partners with REGENXBIO for Exclusive Rights to RGX-111 and RGX-121

Reuters
·
Jan 29

FDA Clinical Hold Knocks REGENXBIO Stock

Benzinga_recent_news
·
Jan 29

BUZZ-U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Danaher, Brinker International

Reuters
·
Jan 28

Regenxbio Shares Plunge on FDA Pausing Two Drug Development Programs

Dow Jones
·
Jan 28

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Ahead of Fed Policy Decision

MT Newswires Live
·
Jan 28

Regenxbio Says RGX-111, RGX-121 Placed on Clinical Hold by FDA; Shares Tumble Pre-Bell

MT Newswires Live
·
Jan 28